メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Better method for detection of CD30: Immunohistochemistry or flow cytometry?

  • Morihiro Higashi
  • , Jun Kikuchi
  • , Chiaki Murakami
  • , Natsuko Takayanagi
  • , Shuji Momose
  • , Masahiro Kizaki
  • , Jun Ichi Tamaru

研究成果: Article査読

抄録

We compared the two methods of assessing CD30 protein expression in DLBCL and TCL specimens routinely employed at our hospital, immunohistochemistry (IHC) and flow cytometry (FCM), using the same clone of the anti-CD30 antibody (Ber-H2) in 123 patients with DLBCL and 28 patients with TCL. FCM was more sensitive than IHC, especially in cases with low expres-sion. In three cases of TCL and two cases of DLBCL, there was discordance between these two methods. Two of these TCL cases were ALCL and one was peripheral T-cell lymphoma, NOS, but ALCL was unable to be excluded. One of two cases of DLBCL was an anaplastic variant of DLBCL. The data suggested that CD30 was undetectable, though rare, by FMC in several cases. Based on this study, a combination of IHC and FCM is recommended for the reliable and quantitative detection of CD30.

本文言語English
ページ(範囲)221-223
ページ数3
ジャーナルJournal of Clinical and Experimental Hematopathology
61
4
DOI
出版ステータスPublished - 2021
外部発表はい

ASJC Scopus subject areas

  • 医学一般

フィンガープリント

「Better method for detection of CD30: Immunohistochemistry or flow cytometry?」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル